对HCC系统治疗的反应评估:当前的挑战和未来的前景.
Mario Matute-González1, Maxime Ronot2,3, Victoria Chernyak4
1BCLC Group, Department of Radiology, Hospital Clínic of Barcelona, IDIBAPS, Barcelona, Spain.
Hepatology (Baltimore, Md.)
|December 16, 2025
概括
肝细胞癌 (HCC) 治疗反应的放射性评估是复杂的,因为肝硬化. 目前的标准,如RECIST 1.1和mRECIST有局限性,需要先进的技术进行准确的评估.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 医疗成像医学成像
背景情况:
- 放射性评估对于预测瘤学治疗疗效和存活率至关重要.
- 肝细胞癌 (HCC) 由于肝硬化相关现象,对放射性评估提出了独特的挑战.
- 对HCC的新系统疗法使反应评估复杂化,质疑现有标准的有效性.
研究的目的:
- 批判性地审查瘤对HCC系统治疗的反应评估.
- 为了突出目前响应标准 (RECIST 1.1,mRECIST) 在HCC中的局限性.
- 探索新兴的放射性评估方法和精密瘤学的未来方向.
主要方法:
- 对已确定的治疗反应标准的审查 (RECIST 1.1,mRECIST).
- 对HCC临床试验和实践的放射性评估中的挑战分析.
- 研究新的方法,如基于免疫疗法的降级和转化疗法.
- 讨论先进的成像技术 (3D成像,AI,放射学).
主要成果:
- 在评估HCC治疗反应时,RECIST 1.1和mRECIST存在局限性.
- 肝硬化和新型疗法使放射学评估复杂化.
- 新兴技术显示出改善治疗评估的前景.
结论:
- 精确的放射性评估HCC治疗反应是具有挑战性的,但至关重要的.
- 先进的成像和人工智能有可能在HCC中进行个性化治疗评估.
- 需要进一步的研究来验证HCC的新标准和技术.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
666
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
